• 2001-2021
    KEEP LIFE FLOWING

    Learn more

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

NEWS

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

26-07-2021
KIDCARES10, First Patient Treated in Pediatric PI Study
Thirty patients aged 2 to 17yo to be enrolled over five European countries
Read all
04-06-2021
Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update
KEDRAB® is now the first and only HRIG available in the U.S. to be clinically studied in children
Read all
14-06-2021
World Blood Donor Day 2021, Kedrion pays tribute to the world of donors
A special edition for Italy, which is hosting the global World Blood Donor Day event
Read all
2020 Annual report
Pharmacovigilance
Medical & Scientific Information